You are here: Home » Reuters » News
Business Standard

Pfizer, Roche and Aspen face South Africa probe over cancer drug prices

Reuters  |  PRETORIA 

PRETORIA (Reuters) - South Africa's competition watchdog has launched an investigation into three pharmaceutical companies suspected of charging excessively for cancer medicines, the agency's head Tembinkosi Bonakele said on Tuesday. The Competition Commission said it will investigate Aspen Pharmacare, Africa's biggest generic drug maker, U.S. company Pfizer and Swiss-based Roche Holding. (Reporting by Nqobile Dludla. Editing by Jane Merriman)(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

This article is no longer available in our repository.

There could be multiple reasons for this.

First Published: Tue, June 13 2017. 17:38 IST